{"id":"https://openalex.org/W4400619808","doi":"https://doi.org/10.1016/j.biopha.2024.117125","title":"PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer","display_name":"PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer","publication_year":2024,"publication_date":"2024-07-14","ids":{"openalex":"https://openalex.org/W4400619808","doi":"https://doi.org/10.1016/j.biopha.2024.117125","pmid":"https://pubmed.ncbi.nlm.nih.gov/39002444","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11384235"},"language":"en","primary_location":{"id":"doi:10.1016/j.biopha.2024.117125","doi":"https://doi.org/10.1016/j.biopha.2024.117125","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopha.2024.117125","pdf_url":null,"source":{"id":"https://openalex.org/S15111687","display_name":"Biomedicine & Pharmacotherapy","issn_l":"0753-3322","issn":["0753-3322","1950-6007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.biopha.2024.117125","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067843261","display_name":"Tayo Alex Adekiya","orcid":"https://orcid.org/0000-0002-3382-9080","observed_orcids":["https://orcid.org/0000-0002-3382-9080"]},"institutions":[{"id":"https://openalex.org/I137853757","display_name":"Howard University","ror":"https://ror.org/05gt1vc06","country_code":"US","type":"education","lineage":["https://openalex.org/I137853757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tayo Alex Adekiya","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA","institution_ids":["https://openalex.org/I137853757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033590190","display_name":"Tamaro Hudson","orcid":"https://orcid.org/0000-0002-1660-1121","observed_orcids":["https://orcid.org/0000-0002-1660-1121"]},"institutions":[{"id":"https://openalex.org/I137853757","display_name":"Howard University","ror":"https://ror.org/05gt1vc06","country_code":"US","type":"education","lineage":["https://openalex.org/I137853757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tamaro Hudson","raw_affiliation_strings":["Cancer Center, Howard University,\u00a0Washington,\u00a0DC 20059,\u00a0USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Howard University,\u00a0Washington,\u00a0DC 20059,\u00a0USA","institution_ids":["https://openalex.org/I137853757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113215888","display_name":"Oladapo Bakare","orcid":"https://orcid.org/0000-0002-9366-9672","observed_orcids":["https://orcid.org/0000-0002-9366-9672"]},"institutions":[{"id":"https://openalex.org/I137853757","display_name":"Howard University","ror":"https://ror.org/05gt1vc06","country_code":"US","type":"education","lineage":["https://openalex.org/I137853757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oladapo Bakare","raw_affiliation_strings":["Department of Chemistry, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA"],"raw_orcid":"https://orcid.org/0000-0002-9366-9672","affiliations":[{"raw_affiliation_string":"Department of Chemistry, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA","institution_ids":["https://openalex.org/I137853757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025418920","display_name":"Edmund Essah Ameyaw","orcid":"https://orcid.org/0000-0002-6999-3077","observed_orcids":["https://orcid.org/0000-0002-6999-3077"]},"institutions":[{"id":"https://openalex.org/I137853757","display_name":"Howard University","ror":"https://ror.org/05gt1vc06","country_code":"US","type":"education","lineage":["https://openalex.org/I137853757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edmund E. Ameyaw","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA","institution_ids":["https://openalex.org/I137853757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078322518","display_name":"Amusa Sarafadeen Adebayo","orcid":"https://orcid.org/0000-0002-3467-2433","observed_orcids":["https://orcid.org/0000-0002-3467-2433"]},"institutions":[{"id":"https://openalex.org/I137853757","display_name":"Howard University","ror":"https://ror.org/05gt1vc06","country_code":"US","type":"education","lineage":["https://openalex.org/I137853757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amusa Adebayo","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA"],"raw_orcid":"https://orcid.org/0000-0002-3467-2433","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA","institution_ids":["https://openalex.org/I137853757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019134982","display_name":"Oluwabukunmi Olajubutu","orcid":"https://orcid.org/0000-0002-9868-1750","observed_orcids":["https://orcid.org/0000-0002-9868-1750"]},"institutions":[{"id":"https://openalex.org/I137853757","display_name":"Howard University","ror":"https://ror.org/05gt1vc06","country_code":"US","type":"education","lineage":["https://openalex.org/I137853757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oluwabukunmi Olajubutu","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA","institution_ids":["https://openalex.org/I137853757"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072940418","display_name":"Simeon Kolawole Adesina","orcid":"https://orcid.org/0000-0002-9841-9971","observed_orcids":["https://orcid.org/0000-0002-9841-9971"]},"institutions":[{"id":"https://openalex.org/I137853757","display_name":"Howard University","ror":"https://ror.org/05gt1vc06","country_code":"US","type":"education","lineage":["https://openalex.org/I137853757"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Simeon K. Adesina","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA. Electronic address: simeon.adesina@howard.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Howard University,\u00a0Washington,\u00a0DC,\u00a0USA. Electronic address: simeon.adesina@howard.edu","institution_ids":["https://openalex.org/I137853757"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5072940418"],"corresponding_institution_ids":["https://openalex.org/I137853757"],"apc_list":{"value":3420,"currency":"USD","value_usd":3420},"apc_paid":{"value":3420,"currency":"USD","value_usd":3420},"fwci":1.8838,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.85246437,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"177","issue":null,"first_page":"117125","last_page":"117125"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9490000009536743},{"id":"https://openalex.org/keywords/brusatol","display_name":"brusatol","score":0.9570000171661377},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-drug-delivery","display_name":"combination drug delivery","score":0.5389999747276306},{"id":"https://openalex.org/keywords/targeted-nanoparticles","display_name":"targeted nanoparticles","score":0.9129999876022339},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.9200000166893005},{"id":"https://openalex.org/keywords/lncap-cells","display_name":"LNCaP cells","score":0.9629999995231628},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.9070000052452087},{"id":"https://openalex.org/keywords/nanotherapeutics","display_name":"nanotherapeutics","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8131077289581299},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7654216289520264},{"id":"https://openalex.org/C20417620","wikidata":"https://www.wikidata.org/wiki/Q4140229","display_name":"Glutamate carboxypeptidase II","level":4,"score":0.7286427021026611},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.5855333209037781},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.574409008026123},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5297167301177979},{"id":"https://openalex.org/C2780165375","wikidata":"https://www.wikidata.org/wiki/Q2102907","display_name":"PLGA","level":3,"score":0.5226069092750549},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.517080545425415},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.45888692140579224},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.41224128007888794},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3884109556674957},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.34246909618377686},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2778993844985962},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17311707139015198},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1645117700099945},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.141012042760849}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000078722","descriptor_name":"PC-3 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000090783","descriptor_name":"Nanoparticle Drug Delivery System","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000954","descriptor_name":"Antigens, Surface","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015027","descriptor_name":"Zebrafish","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043425","descriptor_name":"Glutamate Carboxypeptidase II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.biopha.2024.117125","doi":"https://doi.org/10.1016/j.biopha.2024.117125","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopha.2024.117125","pdf_url":null,"source":{"id":"https://openalex.org/S15111687","display_name":"Biomedicine & Pharmacotherapy","issn_l":"0753-3322","issn":["0753-3322","1950-6007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:39002444","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39002444","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11384235","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11384235","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11384235/pdf/nihms-2011558.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Biomed Pharmacother","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:5ba3dcb51c734baa9b6f64495da7bc27","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5ba3dcb51c734baa9b6f64495da7bc27","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Biomedicine & Pharmacotherapy, Vol 177, Iss , Pp 117125- (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.biopha.2024.117125","doi":"https://doi.org/10.1016/j.biopha.2024.117125","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopha.2024.117125","pdf_url":null,"source":{"id":"https://openalex.org/S15111687","display_name":"Biomedicine & Pharmacotherapy","issn_l":"0753-3322","issn":["0753-3322","1950-6007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & Pharmacotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4450761695","display_name":"Stealth Brusatol and Docetaxel-loaded Nanoparticles for Targeted Prostate Cancer Therapy","funder_award_id":"SC1GM131982","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400619808.pdf","grobid_xml":"https://content.openalex.org/works/W4400619808.grobid-xml"},"referenced_works_count":50,"referenced_works":["https://openalex.org/W73427462","https://openalex.org/W1964429118","https://openalex.org/W2014999922","https://openalex.org/W2018439279","https://openalex.org/W2030940240","https://openalex.org/W2035697316","https://openalex.org/W2038578630","https://openalex.org/W2050958623","https://openalex.org/W2062796491","https://openalex.org/W2074929394","https://openalex.org/W2075153259","https://openalex.org/W2082922390","https://openalex.org/W2088223764","https://openalex.org/W2096406493","https://openalex.org/W2100969980","https://openalex.org/W2104077798","https://openalex.org/W2125363072","https://openalex.org/W2143490989","https://openalex.org/W2155127143","https://openalex.org/W2337863588","https://openalex.org/W2397150638","https://openalex.org/W2403354006","https://openalex.org/W2567412474","https://openalex.org/W2664930764","https://openalex.org/W2757789380","https://openalex.org/W2897075226","https://openalex.org/W2898994124","https://openalex.org/W2943717490","https://openalex.org/W2951461777","https://openalex.org/W2996464220","https://openalex.org/W3005689864","https://openalex.org/W3007033707","https://openalex.org/W3011518560","https://openalex.org/W3112343095","https://openalex.org/W3124321378","https://openalex.org/W3126028722","https://openalex.org/W3155827730","https://openalex.org/W3185965919","https://openalex.org/W3200187442","https://openalex.org/W3215280177","https://openalex.org/W4221082366","https://openalex.org/W4224325912","https://openalex.org/W4280620270","https://openalex.org/W4284965508","https://openalex.org/W4306936773","https://openalex.org/W4310701490","https://openalex.org/W4321375071","https://openalex.org/W4327729660","https://openalex.org/W4390913438","https://openalex.org/W6675429754"],"related_works":["https://openalex.org/W4390913438","https://openalex.org/W4385917784","https://openalex.org/W7128515017","https://openalex.org/W2324631901","https://openalex.org/W2908709516","https://openalex.org/W2494093282","https://openalex.org/W4293068259","https://openalex.org/W4414191189","https://openalex.org/W2987059328","https://openalex.org/W2135486162"],"abstract_inverted_index":{"DCFDA,":[0],"by":[1],"flow":[2],"cytometry.":[3],"PSMA-targeted":[4],"nanoparticles":[5,28,52],"loaded":[6],"with":[7,37,82],"docetaxel":[8,75],"and":[9],"brusatol":[10],"showed":[11],"increased":[12],"ROS":[13],"generation":[14],"in":[15,31,56,76],"LNCaP":[16,39,84],"cells":[17],"compared":[18],"to":[19],"PC-3":[20],"at":[21],"different":[22],"time":[23],"points.":[24],"Furthermore,":[25],"the":[26,44,65,72],"targeted":[27,68],"were":[29],"evaluated":[30],"male":[32,77],"athymic":[33,78],"BALB/c":[34,79],"mice":[35,80],"implanted":[36,81],"PSMA-producing":[38,83],"cell":[40,85],"tumors.":[41,86],"Evaluation":[42],"of":[43,74],"percent":[45],"relative":[46],"tumor":[47,58],"volume":[48],"show":[49,53],"that":[50,64],"brusatol-containing":[51],"great":[54],"promise":[55],"inhibiting":[57],"growth.":[59],"Our":[60],"data":[61],"also":[62],"suggest":[63],"dual":[66],"drug-loaded":[67],"nanoparticle":[69],"platform":[70],"improves":[71],"efficacy":[73]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-07-15T00:00:00"}